Finding new ways to heal eye damage from chemical exposure
Reversing the ocular impact of NM and SM through novel therapies
['FUNDING_OTHER'] · NORTHWESTERN UNIVERSITY AT CHICAGO · NIH-10907615
This study is exploring new ways to help heal eye injuries caused by chemical agents like sulfur mustard, using tiny particles to improve healing and reduce inflammation, so that people with ongoing eye problems can find better relief than what traditional treatments offer.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NORTHWESTERN UNIVERSITY AT CHICAGO (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-10907615 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative therapies to address eye injuries caused by chemical agents, particularly sulfur mustard. It investigates how the eye's surface and tear film respond to damage and aims to enhance healing through the use of synthetic nanoparticles. These nanoparticles are designed to promote re-epithelialization and reduce inflammation, offering a potential alternative to traditional steroid treatments. The research seeks to provide effective long-term solutions for patients suffering from chronic ocular issues following chemical exposure.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced ocular injuries due to chemical agents, particularly those with persistent symptoms following initial treatment.
Not a fit: Patients with eye injuries not related to chemical exposure or those who have fully recovered from their injuries may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healing and reduced long-term complications for patients with eye injuries from chemical exposure.
How similar studies have performed: Previous research has shown promise in using nanoparticles for ocular healing, indicating that this approach may be effective.
Where this research is happening
CHICAGO, UNITED STATES
- NORTHWESTERN UNIVERSITY AT CHICAGO — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LAVKER, ROBERT M — NORTHWESTERN UNIVERSITY AT CHICAGO
- Study coordinator: LAVKER, ROBERT M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.